BACKGROUND:The most common adverse effects of CPAP are related to the upper airways. We evaluated upper-airway symptoms before and after a CPAP trial as well as their effect on CPAP adherence. We also evaluated the effect of humidification added to CPAP therapy on upper-airway symptoms. METHODS: We followed for 1 y 536 subjects with obstructive sleep apnea scheduled consecutively for CPAP initiation. Subjects completed visual analog questionnaires on nasal stuffiness, rhinorrhea, and mouth dryness (0 ؍ no symptoms, 100 ؍ severe symptoms). RESULTS: Before CPAP initiation, mean nasal stuffiness score was 29.6 ؎ 24.9, rhinorrhea score was 16.0 ؎ 21.7, and mouth dryness score was 43.8 ؎ 33.1. In subjects who quit CPAP treatment before the 1-y follow-up, the increase in rhinorrhea score during CPAP initiation was significant, 5.3 (95% CI 0.5-9.5, P ؍ .02), and in those using CPAP at 1 y, nasal stuffiness score and mouth dryness score decreased significantly during initiation, ؊5.1 (95% CI ؊7.9 to ؊2.4, P < .001) and ؊21.2 (؊25.5 to ؊17.4, P < .001). Mouth dryness score decreased significantly with CPAP regardless of humidification: change with humidification, ؊18.1 (95% CI ؊22.1 to ؊14.3), P < .001; change without, ؊10.5 (95% CI ؊16.9 to ؊4.1), P ؍ .002. Humidification also prevented the aggravation of rhinorrhea (change, ؊0.4 [95% CI ؊2.6 to 1.9], P ؍ .75) and alleviated nasal stuffiness (change ؊5.3 [95% CI ؊7.8 to ؊2.6], P < .001) with CPAP, whereas its absence induced a significant rise in symptom scores: change in rhinorrhea, 11.5 (95% CI 7.1-16.7), P < .001; change in nasal stuffiness, 8.5 (95% CI 3.9 -13.5, P < .001). CONCLUSIONS: The severity of upper-airway symptoms before CPAP does not predict CPAP use at 1 y, whereas CPAP non-users at 1 y had smaller or no alleviation in symptom scores during initiation compared with those who continued CPAP treatment.